	Quality and readability of online penile-cancer information: a Cross-Sectional Web Study. Int J Impot Res Ma J, Wang M, Liu Q, Chen Z, Li R, Huang Y, Zhang X. PMID: 42056491 [PubMed - as supplied by publisher]
	Oncological efficacy, functional outcomes and safety of MR-guided ultrasound ablation (MRgFUS/TULSA) for localized prostate cancer: a scoping review. Radiol Med Salvaggio G, Midiri F, Gagliardo C, Salerno S, Lupo G, Benfante V, Comelli A, Lo Re G, Galia M, Midiri M. PMID: 42056384 [PubMed - as supplied by publisher]
	Salvage High-intensity Focused Ultrasound for Prostate Cancer Recurrence after Radiotherapy (HIFI-2 Study). Eur Urol Oncol Ploussard G, Coloby P, Chevallier T, Occéan BV, Kassab D, Houédé N, Villers A, Rischmann P. PMID: 42055879 [PubMed - as supplied by publisher]
	Quantifying the Heterogeneity of TRUS-Visible Lesions for Predicting Prostate Cancer: A Multicenter Preliminary Study. Acad Radiol Zheng B, Zhu J, Xu M, Wu X, Jiang J, Zhang Y, Shen C, Zhang Z, Huang H, Liu X. PMID: 42055868 [PubMed - as supplied by publisher]
	Transcriptome-based Deep Learning Model for Predicting Gemcitabine and Cisplatin Chemotherapy Response in Urothelial Carcinoma: Development and External Validation. Cancer Genomics Proteomics Kang J, Lee HJ, Oh SB, Nam JK, Kim TU, Ryu H, Ki YK, Kang J, Kim YR, Lee JH, Choi J, Hong YJ, Park K. PMID: 42055629 [PubMed - indexed for MEDLINE]
	Integrative multi-omics analysis identifies key ubiquitination regulators in prostate cancer. Transl Oncol Wei H, Gong C, Tan Z, Yang E, Huang Y, An Y, Li H, Lv D, Yang C, Chen W, Wang H, Li S, Ding M, Wang J. PMID: 42055487 [PubMed - as supplied by publisher]
	HSR26-234: Real-World and Clinical Outcomes of Immunotherapy-Based Regimens Versus Tyrosine Kinase Inhibitor Monotherapy in First-Line Metastatic Papillary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. J Natl Compr Canc Netw Vemula SSM, Kamal F, Fernet L, Afridi S, Shah N, Faheem MSB, Gergis S, Isaac D. PMID: 42055426 [PubMed - in process]
	Liquid Biopsy Biomarkers in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Prostate-Specific Membrane Antigen Radioligand Therapy: Protocol for a Prospective, Longitudinal Multicenter Observational Study. JMIR Res Protoc Michalski K, Lorenzini T, Jedamzik T, Heinrich M, Kosmala A, Rauscher I, Bauch M, Reichl L, Amann L, Liebl S, Buck A, Eiber M, Lapa C, Claus R. PMID: 42054640 [PubMed - indexed for MEDLINE]
	Treatment Patterns and Outcomes in Localized Urothelial Carcinoma in Middle-Income Countries: A Multicenter Real-World Study. JCO Glob Oncol Castello Dias Carneiro AP, Batista EC, Gomes Bugano DD, Corradi RG, Panhoca R, Soler JA, Carvalhal E, Ponte de Souza AL, Motke B, Helber HA, Sampaio BDS, Monfardini F, Lamas Assis SR, Rodrigues Sant'Anna VA, Prado Dos Santos G, Lopes da Silva M, Duarte FM, Pereira M, Fagundes Moia DD, Soares RVP, Carneiro A, Perini GF, Rizzo LV, Maluf FC. PMID: 42054609 [PubMed - indexed for MEDLINE]
	International Society of Urological Pathology Consensus on Cancer Precursor Lesions: Working Group 3 Preneoplastic and Precursor Lesions of the Kidney. Am J Surg Pathol Williamson SR, Wobker SE, Mehra R, Al-Obaidy KI, Martignoni G, Mohanty S, Smith SC, Tan PH, Tretiakova M, Kapur P, Wu CL, Akgul M, Sangoi AR, Hakimi AA, Shuch B, Brugarolas J, Kristiansen G, Cheng L, Moch H, And the Members of the ISUP GU Cancer Precursor Consensus Panel. PMID: 42054499 [PubMed - as supplied by publisher]
	The emerging role of the microbiome in bladder cancer: prognostic implications and treatment response. Braz J Med Biol Res Côrtes J, Trindade Filho JCS, Rogatto SR. PMID: 42054198 [PubMed - indexed for MEDLINE]
	Papillary renal neoplasm with reverse polarity: a novel entity for the next WHO classification? a clinical-pathological and molecular study of 15 cases, compared to eosinophilic/oncocytic papillary renal cell carcinoma. Virchows Arch Marletta S, Fiorini D, Caliò A, Marcolini L, Stefanizzi L, Giacometti C, Pedron S, Vicentini C, Martignoni G. PMID: 42053817 [PubMed - as supplied by publisher]
	Bayesian reanalysis of the NIAGARA trial using reconstructed individual patient data: perioperative durvalumab in cisplatin-eligible muscle-invasive bladder cancer. Jpn J Clin Oncol Hirose K, Yoshida S, Chen W, Yajima S, Sato H, Hirakawa A, Tanabe K, Fujiwara M, Fukushima H, Yasuda Y, Tanaka H, Masuda H, Fujii Y. PMID: 42053502 [PubMed - as supplied by publisher]
	A Gene Expression Tumor Signature Optimizing Partial Area-Under-the-Curve (pAUC) to Improve Specificity for Indolent Prostate Cancer. Prostate Gerke TA, Tyekucheva S, Stopsack KH, Sweeney CJ, Lis RT, Westling EN, Loda M, Stampfer MJ, Penney KL, Parmigiani G, Mucci LA. PMID: 42053424 [PubMed - as supplied by publisher]
	Laparoscopic radical cystectomy in patients with bladder cancer: A modified technique with reduced morbidity - A comparative study. Urologia Sharma A, Biswal D, Sharma S, Ravani Thrilochana R, Yadav P, Goel S, Alam P. PMID: 42053413 [PubMed - as supplied by publisher]
	Myosteatosis Predicts Poor Prognosis in Patients With Castration-Resistant Prostate Cancer Treated With Enzalutamide. Int J Urol Kanaki T, Hatano K, Oka T, Tani M, Konishi M, Liu Y, Horitani H, Matsukawa A, Inoguchi S, Yoshimura A, Horibe Y, Sassi N, Okuda Y, Ishizuya Y, Hayashi T, Yamamoto Y, Kato T, Kawashima A, Nonomura N. PMID: 42053360 [PubMed - indexed for MEDLINE]
	Incidence of thromboembolic events in testicular cancer patients receiving cisplatin (TESTCIS study). J Oncol Pharm Pract Dubois M, Joly M, Dionne A, Audet N, Dancause MH. PMID: 42053273 [PubMed - as supplied by publisher]
	Surgical management of metastatic squamous cell carcinoma of the bladder: a case report and review of the literature. Front Oncol Schwartz M, Hartman C, McClintock G, Caulfield S, Jagirdar J, Harik L, Berkowitz D, Fernandez F, Oza S, Narayan V, Brown JT. PMID: 42052454 [PubMed]
	Multilayered analysis of cisplatin resistance mechanisms in bladder cancer: from the cell membrane to organelles. PeerJ Ma L, Tao Y, Cheng L, You C, Xiao X, Yang W, Liu Y, Dong Z. PMID: 42052167 [PubMed - indexed for MEDLINE]
	Detection rate of [(99m)Tc]Tc-PSMA SPECT/CT in prostate cancer: a systematic review and a meta-analysis. Front Med (Lausanne) Albano D, Tasevski S, Sadeghi R, Treglia G, Rizzo A. PMID: 42051703 [PubMed]

Articles 1 - 20 / 177857

Page 1 of 8893



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy